December 9th 2024
Implementing an individualized starting dose (ISD) of niraparib (Zejula; GSK) reduced severe hematologic adverse event (AE) management costs by 48% compared with a fixed starting dose (FSD) in US patients with ovarian cancer.
December 4th 2024
Medicare Advantage Program Linked to Higher Inhaler Adherence in Patients With COPD
August 10th 2024Medicare Advantage beneficiaries with chronic obstructive pulmonary disease (COPD) who were invited to enroll in a program that reduced inhaler costs and provided medication management had higher inhaler adherence; however, there was no significant impact on exacerbations or overall health care spending.
Read More
Hospitals’ Strategies to Reduce Costs and Improve Quality: Survey of Hospital Leaders
Hospitals pursue a broad range of efforts to improve quality, with those participating in bundled payments attempting to reduce postacute care to a greater degree than nonparticipants.
Read More
New Strategic Plan From OXIHER Aims to Bridge Health Equity Gaps in Louisiana
August 7th 2024The Ochsner-Xavier Institute for Health Equity and Research (OXIHER) is targeting health disparities in Louisiana, focusing on population health management, outcomes research, health careers and equity education, community engagement, and health advocacy and policy.
Read More
Decoding Rebates: Study Highlights Need for Further Research into Drug Pricing, Employer PBM Choices
August 7th 2024In the second part of our interview with John M. O'Brien, PharmD, MPH, of the National Pharmaceutical Council (NPC), he calls for further research into employer choices and the influence of benefit consultants in the pharmacy benefit manager (PBM) and drug rebate landscape.
Watch
Tiara Green: Closing Geographic Disparities With Personalized Health Care
August 7th 2024Accessia Health works with advocacy groups to understand specific needs, such as travel assistance, affordable care, and diagnostic testing, ensuring a personalized and human-centered approach to health equity.
Watch
Dr John M. O'Brien Highlights Critical Role of Rebates in Employer Benefit Choices
August 5th 2024John M. O'Brien, PharmD, MPH, of the National Pharmaceutical Council, discusses his recent study, which sheds light on how important rebates are when choosing benefits for employers and who advises employers on these choices.
Read More
Survey Exposes Pervasive Billing Errors, Aggressive Tactics in US Health Insurance
August 5th 2024Almost half of insured Americans report receiving unexpected medical bills, leading to financial strain and contributing to worsening health outcomes for many patients, The Commonwealth Fund report reveals.
Read More